Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

464
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
464
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

149
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
149
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ToxiSpecies: Task-Aware Meta-Learning for Cross-Species Modeling of Acute Chemical Toxicity under Distribution Shift.

Journal of chemical information and modeling·2026
Same author

Generative pretraining for drug molecule design with bidirectional structure-property optimization.

Communications chemistry·2026
Same author

Genome-guided generative adversarial learning enables nanopore adaptive sequencing.

Nature communications·2026
Same author

Fusicoccane glycosides from the endophytic fungus Talaromyces sp. DC-26.

Phytochemistry·2026
Same author

ToxiGuard: an AOP-guided mechanistically interpretable framework for multi-organ toxicity prediction.

Archives of toxicology·2026
Same author

Large-scale data-driven pre-trained DNA models enhance performance across diverse genomics tasks.

Nature communications·2026
Same journal

Literature-informed gene extraction and ranking for multimodal data fusion.

Briefings in bioinformatics·2026
Same journal

SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.

Briefings in bioinformatics·2026
Same journal

Genome assemblies and annotations are not static and need support for tracking their evolution.

Briefings in bioinformatics·2026
Same journal

A historical journey of metabolite-protein interaction discovery: from data harmonization to AI-driven prediction.

Briefings in bioinformatics·2026
Same journal

Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction.

Briefings in bioinformatics·2026
Same journal

Prediction of drug hypersensitivity by comprehensive modeling of HLA-peptidomes.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Oct 21, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

Machine learning methods, databases and tools for drug combination prediction.

Lianlian Wu1, Yuqi Wen2, Dongjin Leng2

  • 1Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.

Briefings in Bioinformatics
|September 3, 2021
PubMed
Summary
This summary is machine-generated.

Predicting novel drug combinations using machine learning (ML) is crucial for treating complex diseases and overcoming drug resistance. This study reviews ML methods and databases for efficient computational drug combination prediction.

Keywords:
deep learningdrug combination databasedrug combination predictionmachine learningsynergy

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K

Related Experiment Videos

Last Updated: Oct 21, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K

Area of Science:

  • Computational biology
  • Pharmacology
  • Artificial intelligence

Background:

  • Combination therapy shows efficacy for complex diseases and reduces drug resistance.
  • Experimental methods for discovering novel drug combinations are insufficient.
  • Efficient computational methods are needed to predict drug combinations and reduce search space.

Purpose of the Study:

  • To introduce and discuss recent applications of machine learning (ML) methods in drug combination prediction.
  • To review widely used databases and tools for drug combination prediction.
  • To summarize challenges and future directions for ML in this field.

Main Methods:

  • Literature review of machine learning algorithms (classic ML and deep learning).
  • Investigation of publicly available databases and prediction tools.
  • Discussion on the concept and controversy of drug combination synergism.

Main Results:

  • Machine learning methods are increasingly applied to improve drug combination prediction.
  • Various data resources and computational tools are available for prediction tasks.
  • Deep learning and classic ML approaches show promise in predicting synergistic drug combinations.

Conclusions:

  • Machine learning offers a powerful approach to accelerate the discovery of effective drug combinations.
  • Further research is needed to address challenges and enhance ML model performance in drug combination prediction.
  • Integration of diverse data sources and advanced ML techniques will be key for future advancements.